<?xml version="1.0" encoding="UTF-8"?>
<p>Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), isolate USA-WA1/2020 was isolated from an oropharyngeal swab of a patient with a respiratory illness. The patient had returned from travel to the affected region of China and had developed clinical disease (COVID-19) in January 2020 in Washington, U.S.A. The sample, NR-52287, as obtained from BEI Resources, NIAID, NIH, consists of a crude preparation of cell lysate and supernatant from Cercopithecus aethiops kidney epithelial cells (Vero E6; ATCC CRL-1586) infected with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate USA-WA1/2020 that was gamma-irradiated (5 Ã— 10
 <sup>6</sup> RADs) on dry ice. The sample, NR-50549, as obtained from BEI Resources, NIAID, NIH, consists of a gamma-irradiated cell lysate and supernatant from Vero cells infected with MERS-CoV, EMC/2012. This sample was isolated from a man with pneumonia in Saudi Arabia.
</p>
